Equities

Klea Holding

Klea Holding

Actions
  • Price (EUR)0.1792
  • Today's Change-0.005 / -2.93%
  • Shares traded152.05k
  • 1 Year change-63.13%
  • Beta-0.7228
Data delayed at least 15 minutes, as of Jul 25 2024 10:57 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Klea Holding formerly, Visiomed Group SA is a France-based holding company. The Company focus on acquiring, developing, and digitizing companies in various sectors to maximize their growth and value. It draws on its experience in developing Smart Salem, the network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates. The Company Smart Health joint venture developed in Saudi Arabia, to extend this entrepreneurial approach to the four corners of the globe. It invests in companies from various sectors in the development phase, both in France and internationally.

  • Revenue in EUR (TTM)13.71m
  • Net income in EUR902.00k
  • Incorporated2009
  • Employees94.00
More ▼

Institutional shareholders

1.60%Per cent of shares held by top holders
HolderShares% Held
Sunny Asset Management SAas of 27 Jun 20243.60m1.17%
MCA Finance SAas of 29 Dec 2023908.29k0.30%
Mandarine Gestion SAas of 14 Sep 2023400.00k0.13%
Gestys SAas of 29 Dec 20230.000.00%
More ▼
Data from 29 Dec 2023 - 27 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.